The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index; none of the 21 sources its claims cite is checked for support yet.
Telomere dysfunction induces metabolic and mitochondrial compromise
Open accessAbstract
Telomere dysfunction activates p53-mediated cellular growth arrest, senescence and apoptosis to drive progressive atrophy and functional decline in high-turnover tissues. The broader adverse impact of telomere dysfunction across many tissues including more quiescent systems prompted transcriptomic network analyses to identify common mechanisms operative in haematopoietic stem cells, heart and liver. These unbiased studies revealed profound repression of peroxisome proliferator-activated receptor gamma, coactivator 1 alpha and beta (PGC-1α and PGC-1β, also known as Ppargc1a and Ppargc1b, respectively) and the downstream network in mice null for either telomerase reverse transcriptase (Tert) or telomerase RNA component (Terc) genes. Consistent with PGCs as master regulators of mitochondrial physiology and metabolism, telomere dysfunction is associated with impaired mitochondrial biogenesis and function, decreased gluconeogenesis, cardiomyopathy, and increased reactive oxygen species. In the setting of telomere dysfunction, enforced Tert or PGC-1α expression or germline deletion of p53 (also known as Trp53) substantially restores PGC network expression, mitochondrial respiration, cardiac function and gluconeogenesis. We demonstrate that telomere dysfunction activates p53 which in turn binds and represses PGC-1α and PGC-1β promoters, thereby forging a direct link between telomere and mitochondrial biology. We propose that this telomere–p53–PGC axis contributes to organ and metabolic failure and to diminishing organismal fitness in the setting of telomere dysfunction.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
Telomere dysfunction in mice represses PGC-1α and PGC-1β through p53, impairing mitochondrial function and metabolism. This telomere–p53–PGC pathway links telomere attrition to cardiomyopathy, defective gluconeogenesis, and stem cell decline.
Key findings
- Transcriptomic profiling of haematopoietic stem cells, heart, and liver from G4 Tert−/− mice showed broad repression of the PGC-1α/β network, including oxidative phosphorylation, oxidative defence, gluconeogenesis, fatty acid/cholesterol synthesis, and β-oxidation genes; RT–qPCR and western blot confirmed lower PGC-1α/β and targets such as NRF-1, ERRα, PPARα, and TFAM.
- Mitochondrial consequences included reduced mitochondrial DNA content and density, lower complex I and IV activity, decreased state III respiration, reduced uncoupled respiration in G4 liver and heart (31% and 25%, respectively), lower ATP synthesis/content, and increased ROS/H2O2 production.
- G4 mice developed dilated cardiomyopathy by 15 months, showed a 30% drop in plasma glucose after 12 h fasting, and had impaired HSC reconstitution; adenoviral Tert partially restored PGC targets and raised glucose by 30% in vivo and 80% in cultured G4 hepatocytes, while adenoviral PGC-1α increased state III and IV respiration in G4 liver mitochondria by 3.1-fold and 3.2-fold.
- p53 deficiency restored PGC expression and mitochondrial DNA copy number; p53–ER activation repressed PGCs and reduced mitochondrial mass by 10–15%; p53 bound PGC-1α/β promoters and repressed reporters fivefold; p53 loss improved fractional shortening by 30% in a doxorubicin cardiomyopathy protocol.
Methods
- Used Tert−/− mice across WT, G1, and G4 generations, Terc−/− G2 mice, and p53−/− backgrounds; profiled HSCs, liver, and heart by microarray with SAM or fold-change analysis and Ingenuity pathway analysis, followed by RT–qPCR and western blot.
- Assessed mitochondrial and metabolic phenotypes via qPCR-based mtDNA quantification, HPLC ATP measurement, Seahorse XF24 and Clark electrode respiration, ROS and carbonylated protein assays, fasting glucose, hepatocyte gluconeogenesis, echocardiography, and competitive transplantation.
- Mechanistic tests included adenoviral Tert or PGC-1α delivery, p53–ER MEF activation, PGC promoter luciferase reporters, anti-p53 chromatin immunoprecipitation, and doxorubicin-induced cardiomyopathy.
Limitations
- No dedicated limitations section is present; the authors state that the relative contributions of DNA damage checkpoints versus metabolic/mitochondrial dysfunction require further study, and that p53-mediated PGC repression is context-dependent.
- Evidence comes from mouse genetic models and cell systems, with no human data; germline p53 deletion and adenoviral overexpression may introduce pleiotropic or context-specific effects.
- The ROS scavenger N-acetylcysteine did not rescue defective HSC repopulation, indicating increased ROS is not central to HSC failure, although its role in other phenotypes is not fully resolved.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
46 Own result · 12 Own interpretation · 11 Not checked yet · 2 Own method
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This impaired mitochondrial ATP synthesis is associated with decreased total ATP content in G4 hearts and livers (Fig. 2d).”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction decreases mitochondrial mass and energy production
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This Ad-PGC-1α impact was markedly more pronounced in G4 mice than in WT mice or hepatocytes.”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction induces pathophysiologies classical for impaired PGC function
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“cultured G4 hepatocytes which show an 80% increase in glucose output relative to Ad-GFP controls”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction induces pathophysiologies classical for impaired PGC function
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“respiration uncoupled from ATP synthesis (induced by 2,4-dinitrophenol, DNP) was also reduced in G4 liver and heart mitochondria (31% and 25%, respectively)”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction decreases mitochondrial mass and energy production
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Functionally, telomere dysfunction correlated with a marked decline in complex I and IV activity when assayed with either whole tissue lysates or isolated mitochondria from G1 and G4 heart and liver tissues”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction decreases mitochondrial mass and energy production
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“G4 mice also showed decreased blood triglyceride and cholesterol levels”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction represses PGC network and mitochondrial biogenesis
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Additionally, complex II- and complex IV-dependent respiration was also decreased in G4 mitochondria”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction decreases mitochondrial mass and energy production
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Telomere dysfunction transcriptomes showed strong enrichment for networks regulated by PGC-1α and PGC-1β including oxidative phosphorylation (OXPHOS), mitochondrial function, oxidative stress and gluconeogenesis”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction represses PGC network and mitochondrial biogenesis
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption: The transcriptomic network analyses used in this study were unbiased.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“while running endurance capacity was significantly reduced in G4 mice”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction represses PGC network and mitochondrial biogenesis
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Ad-Tert had no effect on gluconeogenesis in WT mice”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction induces pathophysiologies classical for impaired PGC function
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 22
- Probably not a substantial claim. 5
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“G4 mice also exhibited an inability to maintain plasma glucose levels under fasting conditions, experiencing a marked 30% drop at 12 h of fasting, yet maintained normal plasma glucose levels under fed conditions”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction induces pathophysiologies classical for impaired PGC function
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In this model, progressive telomere shortening is associated with increasing atrophy and functional decline across proliferative organs (intestinal, haematopoietic) and equally profound impairment in relatively quiescent organs (liver and heart) that do not exhibit significant levels of apoptosis”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction represses PGC network and mitochondrial biogenesis
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“as well as reductions in PGC and targets, mitochondrial DNA content, complex I and IV activity, and ATP levels”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction decreases mitochondrial mass and energy production
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Body composition analysis showed body weight reduction and striking decrease in fat mass with preserved lean mass, yet no differences in spontaneous activity or food intake were apparent”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction represses PGC network and mitochondrial biogenesis
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“this PGC-mitochondrial link is supported by Ad-PGC-1α-induced rescue of gluconeogenesis in vivo and in vitro in G4 hepatocytes”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction induces pathophysiologies classical for impaired PGC function
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“G4 Tert−/− mice exhibited these classical signs of impaired PGC function, including an age-progressive dilated cardiomyopathy with left ventricular wall thinning, increased left ventricular diameter, and reduced fractional shortening by 15 months of age”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction induces pathophysiologies classical for impaired PGC function
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We documented reduced mitochondrial DNA content (Fig. 2a) and reduced mitochondrial density in G1 and G4 heart and liver”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction decreases mitochondrial mass and energy production
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“which aligned with increased ROS levels by FACS in HSCs and increased carbonylated proteins in liver homogenates”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction decreases mitochondrial mass and energy production
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“WT MEF or heart tissues of mice treated with the DNA damage agent doxorubicin showed increased p53 levels after 24 h and coincident binding of p53 to PGC-1α promoter and repression of PGC-1α levels”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > p53 directly represses PGC-1α and PGC-1β
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“anti-p53 chromatin-immunoprecipitation assays in G2 Terc−/− p53+/+, but not G2 Terc−/− p53−/−, MEFs demonstrated physical binding between p53 and (1) PGC-1α fragments containing p53 binding elements at −564 and −954, but not −2317, and (2) PGC1β fragments containing p53 binding elements at −1616 and −1030”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > p53 directly represses PGC-1α and PGC-1β
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“after 48 h of OHT treatment, G2 Terc−/− p53−/− p53–ER MEFs showed a 10–15% decrease in mitochondrial mass compared with no significant change in the OHT-treated G2 Terc−/− p53−/− controls”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > p53 directly represses PGC-1α and PGC-1β
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Increasing dosage of p53 in either p53−/− or G2 p53−/− MEFs showed repressed PGC-1α and PGC-1β levels and increasing occupancy of p53 binding elements in PGC-1α and PGC-1β promoters”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > p53 directly represses PGC-1α and PGC-1β
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Taken together, these collective data establish that telomere-dysfunction-induced repression of the PGC network is associated with mitochondrial dysfunction as evidenced by compromised OXPHOS and respiration, decreased ATP generation capacity, and increased oxidative stress.”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction decreases mitochondrial mass and energy production
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In summary, multiple levels of evidence establish telomere dysfunction-induced p53 represses PGC-1α and PGC-1β, thereby linking telomeres to mitochondrial biology, oxidative defence, and metabolism.”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Discussion
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We demonstrate that telomere dysfunction activates p53 which in turn binds and represses PGC-1α and PGC-1β promoters, thereby forging a direct link between telomere and mitochondrial biology.”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Abstract
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“In the absence of telomerase, continued cell division results in telomere shortening, loss of ‘capping’ function, and p53 activation12-15.”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Abstract
What the sources say
- Not checked yetcites [12] Hastie, N. D. et al. Telomere reduction in human colorectal carcinoma and with ageing. Nature 346, 866–868 (1990) source
- Not checked yetcites [13] Lee, H.-W. et al. Essential role of mouse telomerase in highly proliferative organs. Nature 392, 569–574 (1998) source
- Not checked yetcites [14] Blasco, M. A. et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91, 25–34 (1997) source
- Not checked yetcites [15] Chin, L. et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97, 527–538 (1999) source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We propose that this telomere–p53–PGC axis contributes to organ and metabolic failure and to diminishing organismal fitness in the setting of telomere dysfunction.”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Abstract
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We propose that telomere dysfunction-induced repression of the PGC network and consequent mitochondriopathy and metabolic changes, along with telomere-induced apoptotic and proliferative checkpoints, contributes to functional multi-system decline in the setting of telomere dysfunction.”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Discussion
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“p53 deficiency markedly attenuates the degenerative phenotypes associated with telomere dysfunction, whereas constitutively activated p53 accelerates ageing phenotypes15-18.”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > p53 directly represses PGC-1α and PGC-1β
What the sources say
- Not checked yetcites [15] Chin, L. et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 97, 527–538 (1999) source
- Not checked yetcites [16] Wong, K. K. et al. Telomere dysfunction and Atm deficiency compromises organ homeostasis and accelerates ageing. Nature 421, 643–648 (2003) source
- Not checked yetcites [17] Maier, B. et al. Modulation of mammalian life span by the short isoform of p53. Genes Dev. 18, 306–319 (2004) source
- Not checked yetcites [18] Tyner, S. D. et al. p53 mutant mice that display early ageing-associated phenotypes. Nature 415, 45–53 (2002) source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The relevance of PGCs to age-related pathologies may stem from their regulation of mitochondrial biogenesis and control of metabolic processes (gluconeogenesis, fatty acid metabolism and β-oxidation), processes that relate to increased insulin resistance and diabetes in the aged9.”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Abstract
What the sources say
- Not checked yetcites [9] Lin, J., Handschin, C. & Spiegelman, B. M. Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab. 1, 361–370 (2005) source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“prompted by studies linking impaired mitochondrial function to defective HSC maintenance27-29”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction induces pathophysiologies classical for impaired PGC function
What the sources say
- Not checked yetcites [27] Pannicke, U. et al. Reticular dysgenesis (aleukocytosis) is caused by mutations in the gene encoding mitochondrial adenylate kinase 2. Nature Genet. 41, 101–105 (2008) source
- Not checked yetcites [28] Sankaran, V. G., Orkin, S. H. & Walkley, C. R. Rb intrinsically promotes erythropoiesis by coupling cell cycle exit with mitochondrial biogenesis. Genes Dev. 22, 463–475 (2008) source
- Not checked yetcites [29] Liu, J. et al. Bmi1 regulates mitochondrial function and the DNA damage response pathway. Nature 459, 387–392 (2009) source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Telomere dysfunction activates p53-mediated cellular growth arrest, senescence and apoptosis to drive progressive atrophy and functional decline in high-turnover tissues.”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Abstract
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Previous work has established that repression of either or both co-activators (PGC-1α or PGC-1β) decreases mitochondrial biogenesis and function, elicits cardiomyopathy and impairs de novo glucose production23-25.”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > Telomere dysfunction induces pathophysiologies classical for impaired PGC function
What the sources say
- Not checked yetcites [23] Arany, Z. et al. Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-γ coactivator 1α. Proc. Natl Acad. Sci. USA 103, 10086–10091 (2006) source
- Not checked yetcites [24] Yoon, J. C. et al. Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413, 131–138 (2001) source
- Not checked yetcites [25] Lai, L. et al. Transcriptional coactivators PGC-1α and PGC-lβ control overlapping programs required for perinatal maturation of the heart. Genes Dev. 22, 1948–1961 (2008) source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“qPCR-based mitochondrial quantification was performed with two different primer sets for genomic and mitochondrial loci.”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > METHODS SUMMARY
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“For chromatin immunoprecipitation, we followed the EZ-Chip protocol (Promega) using p53 specific antibody and control IgG.”
§ Telomere dysfunction induces metabolic and mitochondrial compromise > METHODS SUMMARY
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
The paper relies on this without support.
N-acetylcysteine given from birth effectively scavenges reactive oxygen species in the haematopoietic stem cell compartments of G1 and G4 mice.
“G1 or G4 mice treated from birth with N-acetylcysteine, a ROS scavenger, did not rescue defective HSC repopulation in competitive transplantations”
The paper relies on this without support.
The G2 Terc−/− mice used have a degree of telomere dysfunction comparable to that of G4 Tert−/− mice.
“G2 Terc−/− liver and hearts (exhibiting comparable telomere dysfunction as G4 Tert−/− mice)”
The paper relies on this without support.
The transcriptomic network analyses used in this study were unbiased.
“These unbiased studies revealed profound repression of peroxisome proliferator-activated receptor gamma, coactivator 1 alpha and beta”
The paper relies on this without support.
The p53 binding elements identified in the PGC-1α and PGC-1β promoters are the functional sites through which p53 represses these genes.
“anti-p53 chromatin-immunoprecipitation assays in G2 Terc−/− p53+/+, but not G2 Terc−/− p53−/−, MEFs demonstrated physical binding between p53 and (1) PGC-1α fragments containing p53 binding elements at −564 and −954, but not −2317, and (2) PGC1β fragments containing p53 binding elements at −1616 and −1030”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TERC−/− mice present altered mitochondrial functions, including increased production of reactive oxygen species (ROS) from the electron transfer chain (ETC) (Passos et al., 2010; Sahin et al., 2011).”
From P66SHC deletion improves fertility and progeric phenotype of late-generation TERC-deficient mice but not their short lifespan (2016) · cites this paper as Sahin et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, other mutations in genes involved in ROS metabolism, such as SOD2 haploinsufficiency, do not cooperate with telomere dysfunction (Guachalla et al., 2009), and the treatment with N‐acetylcysteine does not rescue progeric phenotypes of late‐generation TERT‐deficient mice (Sahin et al., 2011).”
From P66SHC deletion improves fertility and progeric phenotype of late-generation TERC-deficient mice but not their short lifespan (2016) · cites this paper as Sahin et al., 2011
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The increase in telomere length in quiescent/differentiated tissues could be related to prevention of stress-dependent telomere shortening (Sahin et al, 2011; Sharma et al, 2003), or to re-population of tissues by cells with longer telomeres (Hao et al, 2005).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Sahin et al, 2011
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“p53 activation was found to suppress expression of the PGC-1α and PGC-1β (364), thus linking telomeres to mitochondrial biogenesis.”
From Redox regulation of mitochondrial function (2012) · cites this paper as [364]
The cited source says what the claim attributes to it.
In the citing paper
“In mouse models of accelerated telomere shortening, critically short telomeres have been shown to repress PGC1‐α‐ and β‐mediated mitochondrial biogenesis (Sahin et al, 2011; Chang et al, 2016).”
From Length-independent telomere damage drives post-mitotic cardiomyocyte senescence (2019) · cites this paper as Sahin et al, 2011
The cited source says what the claim attributes to it.
In the citing paper
“Although the rates of stem cell replenishment are unlike to completely account for the telomere length differences observed, we cannot discard other roles of telomerase such as the rescue of telomere shortening through stress protection (Saretzki, 2009) or the recently association to mitochondrial protection in post mitotic tissues (Sahin et al, 2011).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Sahin et al, 2011
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“our sample sizes are similar to those reported in previous publications.15,24,86”
From TERT activation targets DNA methylation and multiple aging hallmarks (2024) · cites this paper as [24]
Experimental — accuracy not yet measuredIn the citing paper
“signaling downstream of short telomeres activates p53, which binds and represses PGC-1α and PGC-1β promoters leading to mitochondrial dysfunction (Sahin et al., 2011).”
From Telomeres and cell senescence—size matters not (2017) · cites this paper as Sahin et al., 2011
In the citing paper
“It is interesting that telomere dysfunction has been associated with changes in mitochondrial metabolism (93)”
From Causes, consequences, and reversal of immune system aging (2013) · cites this paper as [93]
In the citing paper
“more recently it has been recognized that telomere dysfunction causes prominent phenotypes in slow-turnover tissues97,99,100,103 (Table 2).”
From The telomere syndromes (2012) · cites this paper as [103]
In the citing paper
“The telomerase-knockout mouse has provided an important model for understanding telomere-mediated disease mechanisms because there is a remarkable convergence with human disease phenotypes (an overview is shown in Table 2)36,82,84,85,97,99–111.”
From The telomere syndromes (2012) · cites this paper as [103]
In the citing paper
“In these tissues, the metabolic dysfunction appears to be due to the effect of downregulation of PGC1α, which is a transcriptional co-activator that is important for mitochondrial biogenesis103.”
From The telomere syndromes (2012) · cites this paper as [103]
In the citing paper
“Shortened dysfunctional telomeres in other mouse cell types, such as cardiac myocytes and hepatocytes, have also been associated with decreased mitochondrial copy number and defective oxidative metabolism103.”
From The telomere syndromes (2012) · cites this paper as [103]
In the citing paper
“Recent findings correlate deficiency of TERT (and subsequent loss of telomeres) with deficiencies in mitochondrial function attributed to decreases in PGC-1α and PGC-1β expression and suppressed mitochondrial biogenesis (364).”
From Redox regulation of mitochondrial function (2012) · cites this paper as [364]
In the citing paper
“Cellular senescence is thought to further propagate nearby tissue aging through intracellular metabolic compromise (eg, mitochondrial dysfunction) (Sahin et al, 2011) and altered production of secretory factors that promote aging by increasing degradation of nearby tissue and sterile inflammation (Coppe et al, 2010a, b;Freund et al, 2010) (ie, senescence-associated secretory phenotype, SASP).”
From Sleep health: Reciprocal regulation of sleep and innate immunity (2017) · cites this paper as Sahin et al, 2011
In the citing paper
“For example, the tumor suppressor protein, p53, may be activated, which inhibits oxidative defense mechanisms (such as peroxisome proliferator-activated receptor-gamma coactivator [PGC] 1-α and β, promoting mitochondrial damage and senescence or apoptosis (Sahin et al., 2011) (Fig. 2).”
From Psychiatric disorders and leukocyte telomere length: Underlying mechanisms linking mental illness with cellular aging (2015) · cites this paper as Sahin et al., 2011
Citations
Cites
Mitochondria, Oxidants, and Aging
Balaban, R. S., Nemoto, S., & Finkel, T. (2005) · Cell · doi:10.1016/j.cell.2005.02.001 · Cited by 4,388 · cited 1×
“In summary, combined biochemical, genetic and physiological results indicate that (1) activated p53 directly represses PGC-1a and PGC1b, (2) p53 deficiency alleviates transcriptional repression and associated decline in mitochondrial DNA content in tissues and cells with telomere dysfunction, and (3) p53 deficiency pa…”
Wallace, D. C. (2005) · Annual Review of Genetics · doi:10.1146/annurev.genet.39.110304.095751 · Cited by 3,185 · cited 2×
“Finally, anti-p53 chromatin-immunoprecipitation assays in G2 Terc−/− p53+/+, but not G2 Terc−/− p53−/−, MEFs demonstrated physical binding between p53 and (1) PGC-1α fragments containing p53 binding elements at −564 and −954, but not −2317, and (2) PGC1β fragments containing p53 binding elements at −1616 and −1030 (Fi…”
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
Premature ageing in mice expressing defective mitochondrial DNA polymerase
Trifunovic, A., Wredenberg, A., Falkenberg, M., Spelbrink, J. N., Rovio, A. T., Bruder, C. E., Bohlooly-Y, M., Gidlöf, S., Oldfors, A., Wibom, R., et al. (2004) · Nature · doi:10.1038/nature02517 · Cited by 2,734
Metabolic control through the PGC-1 family of transcription coactivators
Lin, J., Handschin, C., & Spiegelman, B. M. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.004 · Cited by 2,130
Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA
Blasco, M. A., Lee, H.-W., Hande, M. P., Samper, E., Lansdorp, P. M., DePinho, R. A., & Greider, C. W. (1997) · Cell · doi:10.1016/s0092-8674(01)80006-4 · Cited by 2,108
Self-citationUnderstanding the odd science of aging
Kirkwood, T. B. L. (2005) · Cell · doi:10.1016/j.cell.2005.01.027 · Cited by 1,984 · cited 2×
“Finally, anti-p53 chromatin-immunoprecipitation assays in G2 Terc−/− p53+/+, but not G2 Terc−/− p53−/−, MEFs demonstrated physical binding between p53 and (1) PGC-1α fragments containing p53 binding elements at −564 and −954, but not −2317, and (2) PGC1β fragments containing p53 binding elements at −1616 and −1030 (Fi…”
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821
Telomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650
p53 Regulates Mitochondrial Respiration
Matoba, S., Kang, J.-G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., & Hwang, P. M. (2006) · Science · doi:10.1126/science.1126863 · Cited by 1,650
Cited by
Sorted by citations
Items 301–400 of 999
Short Telomeres in Key Tissues Initiate Local and Systemic Aging in Zebrafish
Carneiro, M. C., Henriques, C. M., Nabais, J., Ferreira, T., Carvalho, T., & Ferreira, M. G. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005798 · Cited by 87
“Accordingly, less proliferative tissues of TERT knockout mice also have increased production of ROS due to mitochondrial dysfunction [34].”
BackgroundVerhoeven, J. E., Révész, D., Picard, M. A., Epel, E. S., Wolkowitz, O. M., Matthews, K. A., Penninx, B. W. J. H., & Puterman, E. M. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.48 · Cited by 87
Insomnia and Telomere Length in Older Adults
Carroll, J. E., Esquivel, S., Goldberg, A., Seeman, T. E., Effros, R. B., Dock, J., Olmstead, R., Breen, E. C., & Irwin, M. R. (2016) · Sleep · doi:10.5665/sleep.5526 · Cited by 85
Minetti, G., Feige, J. N., Rosenstiel, A., Bombard, F., Meier, V., Werner, A., Bassilana, F., Sailer, A. W., Kahle, P., Lambert, C., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2002038 · Cited by 87
Brunst, K. J., Sánchez-Guerra, M., Gennings, C., Hacker, M. R., Jara, C., Enlow, M. B., Wright, R. O., Baccarelli, A., & Wright, R. J. (2017) · American Journal of Epidemiology · doi:10.1093/aje/kwx183 · Cited by 86
“, telomere shortening and associated DNA damage can promote mitochondrial function) (64).”
Low Social Support Is Associated With Shorter Leukocyte Telomere Length in Late Life
Carroll, J., Roux, A. V. D., Fitzpatrick, A. L., & Seeman, T. E. (2013) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31828233bf · Cited by 87
Longitudinal Associations Between Metabolic Syndrome Components and Telomere Shortening
Révész, D., Milaneschi, Y., Verhoeven, J. E., Lin, J., & Penninx, B. W. J. H. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1995 · Cited by 85
Mitochondrial Function and Dysfunction: An Update
Davis, R. E., & Williams, M. J. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.192104 · Cited by 91
Mitochondria and cellular senescence: Implications for musculoskeletal ageing
Habiballa, L., Salmonowicz, H., & Passos, J. F. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.10.417 · Cited by 82
Brunst, K. J., Sanchez-Guerra, M., Chiu, Y.-H. M., Wilson, A., Coull, B. A., Kloog, I., Schwartz, J., Brennan, K. J., Bosquet Enlow, M., Wright, R. O., et al. (2018) · Environment International · doi:10.1016/j.envint.2017.12.020 · Cited by 81
“…oxidative stress and cellular aging, such as telomere integrity/length, given the reciprocal pathways between mtDNAcn, oxidative damage and telomeres as regulators of cellular and tissue function and their role in environmentally-induced complications (Geronimus et al., 2015; Sahin et al., 2011).”
BackgroundKang, Y., Zhang, H., Zhao, Y., Wang, Y., Wang, W. T., He, Y., Zhang, W. K., Zhang, W., Zhu, X., Zhou, Y., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.02.071 · Cited by 83
Self-citationTelomere shortening and metabolic compromise underlie dystrophic cardiomyopathy
Chang, A. C. Y., Ong, S.-G., LaGory, E. L., Kraft, P. E., Giaccia, A. J., Wu, J. C., & Blau, H. M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615340113 · Cited by 81
“Here we show that activation of p53 in mdx4cv/mTRG2 cardiomyocytes leads to a marked reduction in mitochondrial biogenesis and concomitant decreases in Pgc1α/β, membrane potential, and respiration evident at 8 wk of age, a point at which dilated cardiomyopathy is not evident by electrocardiography, echocardiogram, or…”
BackgroundResultInfluentialThe mitochondrial genome in aging and senescence
Lauri, A., Pompilio, G., & Capogrossi, M. C. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.07.001 · Cited by 80
“The telomere dysfunctionnduced detrimental effect on mitochondria is only partially ediated by p53 as in the Tert−/−p53−/− context PGC1 signalling as substantially but not completely restored (Sahin et al., 2011).”
BackgroundInfluentialEndothelial Aging Associated with Oxidative Stress Can Be Modulated by a Healthy Mediterranean Diet
Marı́n, C., Yubero‐Serrano, E. M., López‐Miranda, J., & Pérez‐Jiménez, F. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14058869 · Cited by 84
“Recent studies in rodents have shown a causal effect of telomerase deficiency and telomere shortening on healthy aging and premature mortality [92,93].”
BackgroundNapoli, M., & Flores, E. R. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.384 · Cited by 80
“These p53-dependent augmented ROS levels can be further increased by the p53mediated repression of PGC-1a and PGC-1b, two transcription factors required for mitochondrial biogenesis, in response to irreparable damage such as telomere shortening (Sahin et al, 2011).”
BackgroundPrather, A. A., Gurfein, B., Moran, P., Daubenmier, J., Acree, M., Bacchetti, P., Sinclair, E., Lin, J., Blackburn, E., Hecht, F. M., et al. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2014.12.011 · Cited by 79
“…to accelerated cellular aging are complex and multifaceted; however, there is growing acceptance that telomere shortening in immune cells is a marker, and possibly a mechanism (Codd et al., 2013; Guo et al., 2011; Sahin et al., 2011), underlying premature morbidity and mortality in humans.”
Chronic pain, perceived stress, and cellular aging: an exploratory study.
Sibille, K. T., Langaee, T., Burkley, B., Gong, Y., Glover, T. L., King, C., Riley, J. L., Leeuwenburgh, C., Staud, R., Bradley, L. A., et al. (2012) · Molecular Pain · doi:10.1186/1744-8069-8-12 · Cited by 80
Xiong, S., Salazar, G., Patrushev, N. A., Ma, M., Forouzandeh, F., Hilenski, L. L., & Alexander, R. W. (2013) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.301019 · Cited by 80
Metabolic roles of PGC-1α and its implications for type 2 diabetes
Besseiche, A., Riveline, J., Gautier, J., Bréant, B., & Blondeau, B. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.02.002 · Cited by 84
“One study suggested that telomere shortenng activates p53, which, in turn, inhibits transcription of PGC(and PGC-1 ), thereby impairing mitochondrial biogenesis, ecreasing gluconeogenesis and increasing reactive oxygen pecies (ROS) production [43].”
BackgroundAge-related neuronal loss in the rat brain starts at the end of adolescence
Morterá, P., & Herculano-Houzel, S. (2012) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2012.00045 · Cited by 79
Telomeres, Nutrition, and Longevity: Can We Really Navigate Our Aging?
Vidaček, N. Š., Nanić, L., Ravlić, S., Sopta, M., Gerić, M., Gajski, G., Garaj‐Vrhovac, V., & Rubelj, I. (2017) · The Journals of Gerontology Series A · doi:10.1093/gerona/glx082 · Cited by 80
Carty, C. L., Kooperberg, C. L., Liu, J., Herndon, M., Assimes, T. L., Hou, L., Kroenke, C. H., LaCroix, A. Z., Kimura, M., Aviv, A., et al. (2015) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.115.305838 · Cited by 83
The problem of genotype and sex differences in life expectancy in transgenic AD mice
Rae, E. A., & Brown, R. E. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.09.002 · Cited by 85
da Luz, P. L., Tanaka, L. Y., Brum, P. C., Dourado, P. M. M., Favarato, D., Krieger, J. E., & Laurindo, F. R. M. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.06.007 · Cited by 77
RECQL4 in genomic instability and aging
Croteau, D. L., Singh, D. K., Ferrarelli, L. H., Lu, H., & Bohr, V. A. (2012) · Trends in Genetics · doi:10.1016/j.tig.2012.08.003 · Cited by 77
The diverse role of the PPARγ coactivator 1 family of transcriptional coactivators in cancer
Girnun, G. D. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.01.007 · Cited by 76
Wells, J. C. K. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9780511972959 · Cited by 83
Targeted DNA damage at individual telomeres disrupts their integrity and triggers cell death
Sun, L., Tan, R., Xu, J., LaFace, J., Gao, Y. D., Xiao, Y., Attar, M. A., Neumann, C. A., Li, G., Su, B., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv598 · Cited by 78
Cau, P., Navarro, C. L., Harhouri, K., Roll, P., Sigaudy, S., Kaspi, É., Perrin, S., Sandre‐Giovannoli, A. D., & Lévy, N. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.03.021 · Cited by 80
SIRT3 protects cells from hypoxia via PGC-1α- and MnSOD-dependent pathways
Wang, Q., Li, L., Li, C. Y., Pei, Z., Zhou, M., & Li, N. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.11.045 · Cited by 77
Yap, J. L. Y., Tai, Y. K., Fröhlich, J., Fong, C. H. H., Yin, J. N., Foo, Z. L., Ramanan, S., Beyer, C., Toh, S. J., Casarosa, M., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201900057r · Cited by 74
“Mitochondrial respiratory capacity and PGC-1a expression have also been linked to telomere maintenance (41).”
BackgroundTelomere shortening and DNA damage of embryonic stem cells induced by cigarette smoke
Huang, J., Okuka, M., Lu, W., Tsibris, J. C. M., McLean, M. P., Keefe, D. L., & Liu, L. (2012) · Reproductive Toxicology · doi:10.1016/j.reprotox.2012.07.003 · Cited by 74
Regeneration of the Aging Lung: A Mini-Review
Navarro, S., & Driscoll, B. (2016) · Gerontology · doi:10.1159/000451081 · Cited by 74
Parallel telomere shortening in multiple body tissues owing to malaria infection
Asghar, M., Palinauskas, V., Zaghdoudi-Allan, N., Valkiūnas, G., Mukhin, A., Platonova, E., Färnert, A., Bensch, S., & Hasselquist, D. (2016) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.2016.1184 · Cited by 73
Mitochondrial Dysfunction in Aging and Cancer
Moro, L. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111983 · Cited by 73
“Alternatively, sinc in progeroid syndrome th te omere dysfu ctio has been hown to impair the mitochondrial function [122], it is possible that n i itial, transient mitochondrial dysfunction may cause prog essive loss of cell fitness and apoptosis via inductio of telomere shortening in a vici us cycl .”
BackgroundAge-associated changes in gene expression in human brain and isolated neurons
Kumar, A., Gibbs, J. R., Beilina, A. G., Dillman, A., Kumaran, R., Trabzuni, D., Ryten, M., WALKER, R. E., Smith, C., Traynor, B. J., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.10.021 · Cited by 77
Shim, H. S., Horner, J. W., Wu, C.-J., Li, J., Lan, Z. D., Jiang, S., Xu, X., Hsu, W.-H., Zal, T., Flores, I. I., et al. (2021) · Nature Aging · doi:10.1038/s43587-021-00146-z · Cited by 73
Self-citationMitochondria as sources and targets of damage in cellular aging
Gómez‐Cabrera, M. C., Sanchis‐Gomar, F., Garcia-Valles, R., Pareja-Galeano, H., Gambini, J., Borrás, C., & Viña, J. (2012) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2011-0795 · Cited by 79
Martínez, P., & Blasco, M. A. (2018) · Circulation Research · doi:10.1161/circresaha.118.312202 · Cited by 74
“The combined PGC1α and PGC1β downregulation results in impaired mitochondrial biogenesis and function, affecting ATP levels, β-oxidation, and fatty acid synthesis in the heart.(62) Thus, telomere dysfunction triggers metabolic changes that may lead to higher level of ROS that in its turn amplify telomere dysfunction.”
BackgroundMitochondrial fatty acid oxidation drives senescence
Yamauchi, S., Sugiura, Y., Yamaguchi, J., Zhou, X., Takenaka, S., Odawara, T., Fukaya, S., Fujisawa, T., Naguro, I., Uchiyama, Y., et al. (2024) · Science Advances · doi:10.1126/sciadv.ado5887 · Cited by 74
“The known mechanisms by which DNA damage affects mitochondria are largely limited to the regulation of mitochondrial biogenesis and mitophagy via transcription factors ( 63 , 64 ).”
Reduced Fetal Telomere Length in Gestational Diabetes
Xu, J., Ye, J., Wu, Y., Zhang, H., Luo, Q., Han, C., Ye, X., Wang, H., He, J., Huang, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086161 · Cited by 73
Telomere regulation in pluripotent stem cells
Huang, Y. Y., Liang, P., Liu, D., Huang, J., & Songyang, Z. (2014) · Protein & Cell · doi:10.1007/s13238-014-0028-1 · Cited by 70
“, 2002), and induces p53 to repress PGC-1α and PGC-1β, thereby linking telomeres to mitochondrial biology, oxidative defense, and metabolism (Sahin et al., 2011).”
BackgroundSaleem, A., Carter, H. N., & Hood, D. A. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00270.2013 · Cited by 73
“We had earlier identified a putative p53 response element in the PGC-1 promoter (13), which was subsequently demonstrated to both suppress (25) and activate transcription of PGC-1 (2).”
Ahmad, F., Patrick, S., Sheikh, T., Sharma, V., Pathak, P., Malgulwar, P. B., Kumar, A., Joshi, S. D., Sarkar, C., & Sen, E. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14152 · Cited by 73
“Telomere dysfunction represses PGC-1a responses and affects mitochondrial biology (Sahin et al. 2011).”
BackgroundPieters, N., Koppen, G., Smeets, K., Napierska, D., Plusquin, M., Prins, S. D., Weghe, H. V. D., Nelen, V., Cox, B., Cuypers, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063208 · Cited by 71
Short Telomere Load, Telomere Length, and Subclinical Atherosclerosis
Fernández-Alvira, J. M., Fuster, V., Dorado, B., Soberón, N. E., Flores, I., Gallardo, M., Pocock, S., Blasco, M. A., & Andrés, V. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.530 · Cited by 72
“Telomere dysfunction induces metabolic and mitochondrial compromise (35), and increased burden of oxidative stress can accelerate LTL attrition (12,29).”
BackgroundGill, J. F., Santos, G., Schnyder, S., & Handschin, C. (2018) · Aging Cell · doi:10.1111/acel.12697 · Cited by 72
“In addition, PGC1a extends health span and life span of a mouse model of premature aging arising from mitochondria defects (Sahin et al., 2011).”
BackgroundMitochondrial responsibility in ageing process: innocent, suspect or guilty
López‐Lluch, G., Santos‐Ocaña, C., Sánchez-Alcázar, J. A., Fernández‐Ayala, D. J. M., Asencio, C., Rodríguez‐Aguilera, J. C., & Navas, P. (2015) · Biogerontology · doi:10.1007/s10522-015-9585-9 · Cited by 72
Savolainen, K., Eriksson, J. G., Kananen, L., Kajantie, E., Pesonen, A., Heinonen, K., & Räikkönen, K. (2014) · Biological Psychology · doi:10.1016/j.biopsycho.2014.02.002 · Cited by 74
The Medical Genome Reference Bank contains whole genome and phenotype data of 2570 healthy elderly
Pinese, M., Lacaze, P., Rath, E. M., Stone, A., Brion, M.-J., Ameur, A., Nagpal, S., Puttick, C., Husson, S., Degrave, D., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14079-0 · Cited by 70
Integrating Physiological Regulation with Stem Cell and Tissue Homeostasis
Nakada, D., Levi, B. P., & Morrison, S. J. (2011) · Neuron · doi:10.1016/j.neuron.2011.05.011 · Cited by 78
IKKα and alternative NF-κB regulate PGC-1β to promote oxidative muscle metabolism
Bakkar, N., Ladner, K. J., Canan, B. D., Liyanarachchi, S., Bal, N. C., Pant, M., Periasamy, M., Li, Q., Janssen, P. M. L., & Guttridge, D. C. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201108118 · Cited by 74
Metabolic Dysfunction Consistent With Premature Aging Results From Deletion of Pim Kinases
Din, S., Konstandin, M. H., Johnson, B., Emathinger, J. M., Völkers, M., Toko, H., Collins, B. L., Ormachea, L., Samse, K. M., Kubli, D. A., et al. (2014) · Circulation Research · doi:10.1161/circresaha.115.304441 · Cited by 71
PGC‐1α, a potential therapeutic target against kidney aging
Lee, G.-Y., Uddin, M. J., Kim, Y., Ko, M., Yu, I., & Ha, H. (2019) · Aging Cell · doi:10.1111/acel.12994 · Cited by 71
“PGC‐1α expression is decreased in TERT‐knock‐ out mice (Kang et al., 2018; Sahin et al., 2011).”
Backgroundvan Beek, H., Kirkwood, T. B. L., & Bassingthwaighte, J. B. (2016) · Interface Focus · doi:10.1098/rsfs.2015.0079 · Cited by 77
Basilio, E., Chen, R., Fernandez, A. C., Padula, A. M., Robinson, J. F., & Gaw, S. L. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192113727 · Cited by 70
“Placental studies have shown that exposure to tobacco during pregnancy is associated with lower birth weight and lower relative mitochondrial DNA which can be used as a marker of mitochondrial damage and dysfunction [143].”
BackgroundIrisin Improves Autophagy of Aged Hepatocytes via Increasing Telomerase Activity in Liver Injury
Bi, J.-B., Yang, L.-F., Wang, T., Zhang, J., Li, T., Ren, Y., Wang, M.-Z., Chen, X., Lv, Y., & Wu, R. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/6946037 · Cited by 66
“Telomerase reverse transcriptase- (TERT-) deficient mice showed significant mitochondrial dysfunction and oxidative stress [11].”
BackgroundChen, S., Yeh, F., Lin, J., Matsuguchi, T., Blackburn, E. H., Lee, E. T., Howard, B. V., & Zhao, J. (2014) · Aging · doi:10.18632/aging.100664 · Cited by 67
“A previous study in mice demonstrated that telomere shortening may contribute to metabolic dysfunction through its impact on mitochondrial biogenesis [28].”
BackgroundThe Complex Interaction of Mitochondrial Genetics and Mitochondrial Pathways in Psychiatric Disease
Cuperfain, A. B., Zhang, Z. L., Kennedy, J. L., & Gonçalves, V. F. (2018) · Complex Psychiatry · doi:10.1159/000488031 · Cited by 67
β-Hydroxy-β-methylbutyrate, mitochondrial biogenesis, and skeletal muscle health
He, X., Duan, Y., Yao, K., Li, F., Hou, Y., Wu, G., & Yin, Y. (2016) · Amino Acids · doi:10.1007/s00726-015-2126-7 · Cited by 70
“Impaired mitochondrial function is characterized by a rapid onset of symptoms commonly seen in the elderly, including muscle loss and insulin resistance (Wallace 2010; Sahin et al. 2011).”
BackgroundMitochondria and Oxidative Stress in the Cardiorenal Metabolic Syndrome
Aroor, A. R., Mandavia, C. H., Ren, J. T., Sowers, J. R., & Pulakat, L. (2012) · Cardiorenal Medicine · doi:10.1159/000335675 · Cited by 67
Li, Q., Du, J., Feng, R., Xu, Y., Wang, H., Sang, Q., Xing, Q., Zhao, X., Li, J., He, L., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3685 · Cited by 66
“In addition, telomere shortening can cause dysregulation of the insulin secretion signaling pathway, mitochondrial function, and Ca(2) metabolism in vivo (41, 42).”
Dioguardi, C. C., Uslu, B., Haynes, M., Kuruş, M., Gül, M., Miao, D., Santis, L. D., Ferrari, M., Bellone, S., Santin, A. D., et al. (2016) · Molecular Human Reproduction · doi:10.1093/molehr/gaw023 · Cited by 67
RETRACTED ARTICLE:Exercise-induced mitochondrial p53 repairs mtDNA mutations in mutator mice
Safdar, A., Khrapko, K., Flynn, J. M., Saleem, A., Lisio, M. D., Johnston, A. P. W., Kratysberg, Y., Samjoo, I. A., Kitaoka, Y., Ogborn, D. I., et al. (2015) · Skeletal Muscle · doi:10.1186/s13395-016-0075-9 · Cited by 68
“Similar phenotypes have also been reported in telomerase-deficient mice [5], where telomere dysfunction is associated with impaired mitochondrial biogenesis and metabolic failure resulting in progressive tissue atrophy, stem cell depletion, organ system failure, and impaired tissue injury responses as seen with aging…”
BackgroundInfluentialRetractedNon-canonical Functions of Telomerase Reverse Transcriptase: Emerging Roles and Biological Relevance
Thompson, C. A. H., & Wong, J. M. Y. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200131125110 · Cited by 67
Association of Parental Socioeconomic Status and Newborn Telomere Length
Martens, D. S., Janssen, B. G., Bijnens, E. M., Clemente, D. B. P., Vineis, P., Plusquin, M., & Nawrot, T. S. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.4057 · Cited by 68
ZBTB48 is both a vertebrate telomere‐binding protein and a transcriptional activator
Jahn, A., Rane, G., Paszkowski‐Rogacz, M., Sayols, S., Bluhm, A., Han, T., Drašković, I., Londoño‐Vallejo, A., Kumar, A. P., Buchholz, F., et al. (2017) · EMBO Reports · doi:10.15252/embr.201744095 · Cited by 61
“In particular, metabolic disorders tightly link telomeres to mitochondrial metabolism and dysfunctions in telomeres and telomeric proteins have been shown to compromise mitochondrial homeostasis and vice versa [7,8].”
InfluentialMinutes of PPAR-γ agonism and neuroprotection
Kumar, B. R. P., Kumar, A. P., Jose, J. A., Prabhakaran, P., Yuvaraj, S., Chipurupalli, S., Jeyarani, V., Manisha, C., Banerjee, S., Jeyabalan, J. B., et al. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104814 · Cited by 66
Habitual physical exercise has beneficial effects on telomere length in postmenopausal women
Kim, J., Ko, J., Lee, D., Lim, I., & Bang, H. (2012) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3182503e97 · Cited by 64
Early-life stress and reproductive cost: A two-hit developmental model of accelerated aging?
Shalev, I., & Belsky, J. (2016) · Medical Hypotheses · doi:10.1016/j.mehy.2016.03.002 · Cited by 66
“biogenesis and function, likely through transcriptional regulators involved in energy metabolism [23].”
BackgroundTP53 mutation, mitochondria and cancer
Kamp, W. M., Wang, P., & Hwang, P. M. (2016) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2016.02.007 · Cited by 63
Janssen, B. G., Gyselaers, W., Byun, H., Roels, H. A., Cuypers, A., Baccarelli, A., & Nawrot, T. S. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-016-1113-4 · Cited by 63
“As a result, alterations in mtDNA content, characterized as increasing or decreasing mtDNA copies, are an indication of dysfunctional or damaged mitochondria [10].”
BackgroundMyricetin improves endurance capacity and mitochondrial density by activating SIRT1 and PGC-1α
Jung, H., Lee, D.-Y., Ryu, H. G., Choi, B.-H., Go, Y., Lee, N., Lee, D., Son, H. G., Jeon, J., Kim, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-05303-2 · Cited by 67
Proinflammatory T Cell Status Associated with Early Life Adversity
Elwenspoek, M. M. C., Hengesch, X., Leenen, F. A. D., Schritz, A., Sias, K., Schaan, V., Mériaux, S. B., Schmitz, S., Bonnemberger, F., Schächinger, H., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1701082 · Cited by 67
Guo, Q., Guo, J., Yang, R., Peng, H., Zhao, J., Li, L., & Peng, S. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/151972 · Cited by 63
Ertel, A., Tsirigos, A., Whitaker‐Menezes, D., Birbe, R., Pavlides, S., Martinez‐Outschoorn, U., Pestell, R. G., Howell, A., Sotgia, F., & Lisanti, M. P. (2012) · Cell Cycle · doi:10.4161/cc.11.2.19006 · Cited by 64
Antunes, D. M. F., Kalmbach, K., Wang, F., Dracxler, R. C., Seth-Smith, M. L., Kramer, Y. G., Buldo-Licciardi, J., Kohlrausch, F. B., & Keefe, D. L. (2015) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-015-0574-3 · Cited by 63
“Telomere length (TL) is known to affect aging and longevity, cell division, meiosis, and fertility [2–6].”
BackgroundMitochondrial Metabolism in T Cell Activation and Senescence: A Mini-Review
Ron‐Harel, N., Sharpe, A. H., & Haigis, M. C. (2014) · Gerontology · doi:10.1159/000362502 · Cited by 66
Re‐equilibration of imbalanced NAD metabolism ameliorates the impact of telomere dysfunction
Sun, C., Wang, K., Stock, A. J., Gong, Y., Demarest, T. G., Yang, B., Giri, N., Harrington, L. A., Alter, B. P., Savage, S. A., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019103420 · Cited by 67
“A previous study reported that telomere attrition/dysfunction led to repression of PGC-1 a and mitochondrial dysfunction in mice (Sahin et al , 2011).”
Comparative endothelial profiling of doxorubicin and daunorubicin in cultured endothelial cells
Wójcik, T., Buczek, E., Majzner, K., Kołodziejczyk, A. M., Miszczyk, J. U., Kaczara, P., Kwiatek, W. M., Barańśka, M., Szymoński, M., & Chłopicki, S. (2014) · Toxicology in Vitro · doi:10.1016/j.tiv.2014.12.009 · Cited by 62
“…which is linked to the inhibition of topoisomerase II and the subsequent ATM/ATR-regulated DNA damage-dependent stress responses (Shiloh, 2001), such as the accumulation of p53 protein and the phosphorylation of Chk-1 (Damrot et al., 2006), and mitochondrial abnormalities (Sahin et al., 2011).”
Sun, X., Johnson, J. L., & John, J. C. S. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky339 · Cited by 62
p53 plays a crucial role in endothelial dysfunction associated with hyperglycemia and ischemia
Yokoyama, M., Shimizu, I., Nagasawa, A., Yoshida, Y., Katsuumi, G., Wakasugi, T., Hayashi, Y., Ikegami, R., Suda, M., Ota, Y., et al. (2019) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.02.010 · Cited by 63
Puterman, E., Epel, E. S., Lin, J., Blackburn, E. H., Gross, J. J., Whooley, M. A., & Cohen, B. E. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.05.008 · Cited by 61
“Telomeres are not solely biomarkers of disease, as experiments in rodents implicate telomere shortening and lower telomerase activity as causes of mitochondrial damage, increased oxidative stress, and damage to tissues (Jaskelioff et al., 2011; Perez-Rivero et al., 2006; Sahin et al., 2011).”
Telomere Shortening and Psychiatric Disorders: A Systematic Review
Pousa, P. A., de Souza, R. M., Melo, P. H. M., Correa, B. H. M., Mendonça, T. S. C., Silva, A. C. S. E., & de Miranda, D. M. (2021) · Cells · doi:10.3390/cells10061423 · Cited by 63
“In both scenarios, p53′s release causes the suppression of PGC-1α and PGC-1β and their downstream targets, resulting in disturbed oxidative phosphorylation, increased ROS and diminished ATP production and gluconeogenesis [178,183].”
BackgroundWu, L., Sowers, J. R., Zhang, Y., & Ren, J. T. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac080 · Cited by 65
Lamins as mediators of oxidative stress
Sieprath, T., Darwiche, R., & Vos, W. H. D. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.04.058 · Cited by 67
Telomeres, Atherosclerosis, and Human Longevity
Aviv, A., Kark, J. D., & Susser, E. (2015) · Epidemiology · doi:10.1097/ede.0000000000000280 · Cited by 60
“Finally, although oxidative stress might augment leukocyte telomere length attrition to some extent, in genetically engineered mice with ablated telomerase, short telomeres impair mitochondrial biogenesis so as to increase the output of reactive oxygen species and compromise organ function.(43) thus, the cause-and-eff…”
BackgroundPillai, V. B., Samant, S. A., Hund, S., Gupta, M., & Gupta, M. P. (2021) · Aging · doi:10.18632/aging.203027 · Cited by 62
“In the Tert −/− and Terc −/− mice, telomere dysfunction induces mitochondrial defects, leading to cardiac aging and heart failure [44, 70].”
Mitochondrial dysfunction and aging: multidimensional mechanisms and therapeutic strategies
Wei, P., Zhang, X., Yan, C., Sun, S., Chen, Z., & Lin, F. (2025) · Biogerontology · doi:10.1007/s10522-025-10273-4 · Cited by 68
“This telomere–p53–PGC axis drives multiorgan dysfunction and metabolic deterioration under conditions of telomere attrition (Sahin et al. 2011).”
Neuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosis
Nicolai, S., Pieraccioli, M., Peschiaroli, A., Melino, G., & Raschellà, G. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.354 · Cited by 62
Li, Z., Hu, M., Zong, X., Hé, Y., Wang, D., Dai, L., Dong, M., Zhou, J., Cao, H., Lv, L., et al. (2015) · Scientific Reports · doi:10.1038/srep18553 · Cited by 61
Akino, N., Wada‐Hiraike, O., Isono, W., Terao, H., Honjo, H., Miyamoto, Y., Tanikawa, M., Sone, K., Hirano, M., Harada, M., et al. (2019) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-019-0466-y · Cited by 60
Abd‐Elhakim, Y. M., Mohamed, A. A.-R., Khater, S. I., Arisha, A. H., Metwally, M. M. M., NASSAN, M. A., & Hassan, M. E. (2020) · Antioxidants · doi:10.3390/antiox10010017 · Cited by 59
“Additionally, the notable downregulation of PGC-1α and SIRT1 indicates the spermatogenic mitochondrial compromise by ROS due to T2DM induced hyperglycemia.”
BackgroundInfluentialImplications of telomere‐independent activities of telomerase reverse transcriptase in human cancer
Ding, D., Zhou, J., Wang, M., & Cong, Y. (2013) · FEBS Journal · doi:10.1111/febs.12258 · Cited by 61
Sanderson, S., & Simon, A. K. (2017) · Aging Cell · doi:10.1111/acel.12640 · Cited by 59
“Our data alongside published literature (Son et al. , 2000) demonstrate that cell types in mixed populations have different telomere lengths; therefore, the inclusion of surface markers to identify cell populations is critical.”
MethodMitochondrial remodeling in mice with cardiomyocyte-specific lipid overload
Elezaby, A., Sverdlov, A. L., Tu, V. H., Soni, K., Luptak, I., Qin, F., Liesa, M., Shirihai, O. S., Rimer, J. M., Schaffer, J. E., et al. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.12.001 · Cited by 59
“5μM) to avoid the reverse electron transfer effect [19].”
BackgroundSelf-citationMitochondria and Tumor Progression in Ulcerative Colitis
Ussakli, C., Ebaee, A., Binkley, J., Brentnall, T. A., Emond, M. J., Rabinovitch, P. S., & Risques, R. A. (2013) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djt167 · Cited by 58
“The fact that both cellular events show identical bimodal distributions raises the possibility of a potential association, which is strengthened by the recently discovered link between short telomeres and mitochondrial dysfunction in telomerase knockout mice (28).”
BackgroundLe, R., Kou, Z., Jiang, Y., Li, M., Huang, B. S., Liu, W., Li, H., Kou, X., He, W., Rudolph, K. L., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.11.005 · Cited by 58
“Mitochondrial Dysfunction in G3 iPSCs Is Independent of PGC Network Repression In Terc / somatic cells, mitochondrial dysfunction is caused by the telomere-p53-PGC axis (Sahin et al., 2011), which prompted us to analyze the PGC network in G3 iPSCs and ntESCs.”
BackgroundMethodInfluentialLiu, S., Kim, T.-H., Franklin, D. A., & Zhang, Y. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.086 · Cited by 57
“Consistent with the previous observations in mouse adipose tissue and other publications (Chen et al., 2005; Sahin et al., 2011; Schwartzenberg-Bar-Yoseph et al., 2004), p53 induction in 3T3-L1 adipocytes suppressed the expression of Glut4, Glut1, Sirt1, Liu et al.”
ResultKamogashira, T., Hayashi, K., Fujimoto, C., Iwasaki, S., & Yamasoba, T. (2017) · npj Aging and Mechanisms of Disease · doi:10.1038/s41514-017-0002-2 · Cited by 60
Metadata
- Authors
- Sahin, E., Colla, S., Liesa, M., Moslehi, J., Müller, F. L., Guo, M., Cooper, M., Kotton, D., Fabian, A. J., Walkey, C., Maser, R. S., Tonon, G., Foerster, F., Xiong, R., Wang, Y. A., Shukla, S. A., Jaskelioff, M., Martin, E. S., Heffernan, T. P., Protopopov, A., Ivanova, E., Mahoney, J. E., Kost-Alimova, M., Perry, S. R., Bronson, R., Liao, R., Mulligan, R., Shirihai, O. S., Chin, L., & DePinho, R. A.
- Affiliations
- Dana-Farber Cancer Institute (US)
- Harvard University (US)
- Boston University (US)
- Brigham and Women's Hospital (US)
- University of Massachusetts Chan Medical School (US)
- The University of Melbourne (AU)
- Corresponding author
- DePinho, Ronald A.
- ORCID
- Sahin, Ergün
- Colla, Simona
- Liesa, Marc
- Moslehi, Javid
- Müller, Florian L.
- Kotton, Darrell
- Walkey, Carl
- Tonon, Giovanni
- Foerster, Friedrich
- Wang, Y. Alan
- Shukla, Sachet A.
- Jaskelioff, Mariela
- Martin, Eric S.
- Heffernan, Timothy P.
- Protopopov, Alexei
- Ivanova, Elena
- Mahoney, John E.
- Bronson, Roderick
- Liao, Ronglih
- Shirihai, Orian S.
- DePinho, Ronald A.
- Venue
- Nature
- Published
- 2011-02-09
- Volume
- 470
- Issue
- 7334
- Pages
- 359-365
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3741661
- OpenAlex
- W2124098526
- Semantic Scholar
- 14115a60df726b2a29c3a0b4d83e9f284c2371bb
- Cited by
- 1,319
- References
- 49
- Citations by year
- 2026: 50 · 2025: 58 · 2024: 73 · 2023: 87 · 2022: 83 · 2021: 100 · 2020: 78 · 2019: 84 · 2018: 81 · 2017: 88 · 2016: 91 · 2015: 93 · 2014: 83 · 2013: 94 · 2012: 111
- FWCI
- 76.58
- Type
- journal article
- Language
- en
- Update notices
- erratum (2011-06-22)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Funders
- National Cancer Institute (R01CA084628)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK035914, R01DK089185, U24DK59635, P30DK046200, U24DK059635, R01DK063356, R01DK056690, P30DK079638)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- telomere dysfunction, p53, PGC-1α, PGC-1β, telomerase reverse transcriptase, telomerase RNA, mitochondrial biogenesis, mitochondrial dysfunction, gluconeogenesis, cardiomyopathy, reactive oxygen species, cellular senescence, hematopoietic stem cells, liver, heart, aging, transcriptional repression
- MeSH terms
- Adenosine Triphosphate, Aging, Animals, DNA, Mitochondrial, Doxorubicin, Gluconeogenesis, Hematopoietic Stem Cells, Liver, Mitochondria, Cardiomyopathies, Myocardium, RNA, Transcription Factors, Tumor Suppressor Protein p53, Telomere, Reactive Oxygen Species, Telomerase, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-06, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-06 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
